![](/img/cover-not-exists.png)
Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomas
Fabio M. Iwamoto, Teri N. Kreisl, Lyndon Kim, J. Paul Duic, John A. Butman, Paul S. Albert, Howard A. FineVolume:
116
Year:
2010
Language:
english
Pages:
7
DOI:
10.1002/cncr.24957
File:
PDF, 175 KB
english, 2010